Cost-Utility Analysis of Enzalutamide for Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer (MCRPC)
May 1, 2014, 00:00
10.1016/j.jval.2014.03.521
https://www.valueinhealthjournal.com/article/S1098-3015(14)00572-5/fulltext
Title :
Cost-Utility Analysis of Enzalutamide for Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer (MCRPC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00572-5&doi=10.1016/j.jval.2014.03.521
First page :
A89
Section Title :
Cancer
Open access? :
No
Section Order :
1570